DENVER--(BUSINESS WIRE)--HEART RHYTHM 2010 – Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to ...
February 5, 2010 (Washington, DC) — Transvenous extraction of implanted-device leads using a laser catheter is nearly always completed successfully and poses little risk of death or other major ...
October 11, 2011 (Miami, Florida) — Percutaneous removal of pacemaker and implantable cardioverter defibrillator (ICD) leads using a laser catheter can be achieved as effectively and safely in ...
COLORADO SPRINGS, Colo., Feb. 08, 2016 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) clearance ...
COLORADO SPRINGS, Colo., Dec. 8, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission ...
Spectranetics is a medical device company that develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in ...
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Excimer laser procedure to be tested on more than 350 patients. COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Spectranetics Corporation (Nasdaq:SPNC - News) today announced that it plans to initiate the ...
This study on the Pacemaker/Defibrillator Lead Extraction Kits Market is a data-driven insight into its key evolution trajectories and scrutiny of the current and emerging avenues in the various ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC - News) today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to ...
COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback